LAG3 and neoplasm: Very recently a combination study showed that simultaneous PD-1 and LAG-3 blockade exerted an increased effect in the maintenance of T cell activity in vitro, evaluated as cytokines release, and resulted in delayed tumor growth and survival benefit in vivo in a syngenic mouse model of MPM respect to single ICI treatment [54].